LAT1 antibody | knockout validation | TransGenic Inc. KE026
DOI
//dx.doi.org/10.13070/ko.en.6.1800
Date
2016-11-08

This is a knockout-validated antibody summary, based on the publication "Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit polyclonal

Company: TransGenic Inc.

Antibody: LAT1

Catalog number: KE026

Summary: Rabbit polyclonal antibody raised against a synthetic peptide corresponding to the C-terminal region of human LAT.

The antibody was antigen affinity purified.

Validation Method

Western blot

Immunofluorescence

Sample

Western blot: Lysates of wild-type and LAT1 -/- LS174T human colon adenocarcinoma cells.

Immunofluorescence: Wild-type and LAT1 -/- LS174T cells.

Fixed with 3% paraformaldehyde and permeabilised with 0.2% Triton X-100 in PBS.

Blocking agent

Western blot: 5% milk powder in TBS.

Immunofluorescence: Not stated.

Primary incubation

Western blot: 1:1000 dilution.

Immunofluorescence

Secondary incubation

Western blot: HRP-conjugated anti-rabbit antibody (Promega).

Immunofluorescence: 1:1000 dilution of FluoProbe594-conjugated anti-rabbit antibody (FP-SD 5110-T, Interchim).

Detection

Western blot: ECL (Merck Millipore) in conjunction with LI-COR Odyssey Imaging System.

Immunofluorescence: Leica SP5 confocal microscope with LS AF and Image J software.

Figure

See figure 1 from the article [1].

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Cormerais Y, Giuliano S, Lefloch R, Front B, Durivault J, Tambutte E, et al. Genetic disruption of the multifunctional CD98/LAT1 complex demonstrates the key role of essential amino acid transport in the control of mTORC1 and tumor growth. Cancer Res. 2016;: pubmed